Latest News
Global MS patient-centred initiative launches
As the member organisation of the MS International Federation (MSIF) in Australia, MS Australia is delighted to share news of an important new global initiative.
Launching today (12/09/19) at the ...
PBAC recommends listing of two MS medications for children with relapsing remitting MS
On Friday 23 August, the Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing of two MS medications for children with relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS).
The two recommendations made by PBAC are as follows:
...
Meeting the needs of people living with MS, their families and carers
Released today (Monday 19/8/19) a Report of the key results of a study into the needs of people living with MS, their families and carers.
A big thank you to all those who participated in this important project!
MS Australia releases findings of...
Tim's Fast Life on Wheels
Reproduced with the kind permission of Link:
https://linkonline.com.au/assets/attachments/blog/72/link-august-2019-web.pdf
Comedian...
Oceans of Hope announce New Zealand return and invitation to Aussie sailors with MS
A recent announcement from the Oceans of Hope team:
We are pleased to announce that Oceans of Hope UK will be returning to New Zealand in 2019. We have been working with our friends at MSNZ and ...
Communication with your Carer: How to set up Great Expectations
Old patterns are hard to break, and if you leave things too long, it can feel too awkward to bring them up.
Even when someone is a paid professional health care worker doing their job, it can be hard to approach them objectively, dispassionately and unapologetically to ask...
Legendary Tony & Grammy Award-winning Broadway star with MS to perform in Sydney
The original Dreamgirl and Broadway icon…Tony and Grammy Award Winning…Jennifer Holliday is set to make her Australian Debut!
Famous for her huge hit and show stopping performance of,...
World MS Day 2019
World MS Day 2019 on Thursday 30 May is an annual global day to raise awareness about multiple sclerosis (MS) and the needs of people living with the condition.
This year’s theme,...
TGA approval of Gilenya® (fingolimod) as first licensed oral treatment for paediatric MS
On Wednesday 1 May 2019, Novartis announced that the Therapeutic Goods Administration (TGA) has approved Gilenya® (fingolimod) for the treatment of children and adolescents 10-17 years old with relapsing forms of multiple sclerosis.
The registration makes Gilenya the first licenced...
Alemtuzumab (Lemtrada®) under safety review by European Medicines Agency
Alemtuzumab (Lemtrada®), one of the approved treatments for relapsing MS in Australia, is being reviewed as a first line therapy by regulatory bodies overseas. The European Medicines Agency (EMA) has started a safety review of alemtuzumab based on new reports overseas of rare but...
BUDGET 2019 – Both parties set the scene for the Federal Election
As many commentators have already said, this year’s Federal Budget is unusual. More than a month early, it marks the beginning of an election campaign, rather than setting out a national economic plan, with the Federal Election 2019 date to be announced shortly.
For people living with MS...
MS Australia - Media Statement: PRIME MINISTER SCOTT MORRISON ANNOUNCES ROYAL COMMISSION INTO DISABILITY
MS Australia (MSA) welcomes today’s announcement by the Prime Minister, of the Royal Commission into Disability and his commitment, dedication and recognition of the challenges faced by people affected by multiple sclerosis (MS).
It’s important that this inquiry develops a fuller picture...